- Kyowa Kirin Provides Update on Application for Marketing Authorisation of Istradefylline in Europe for the Treatment of ‘OFF’ Episodes in People Living with Parkinson’s
- Kyowa Kirin Announces EU Approval for the Self-administration of CRYSVITA® ▼ (burosumab) to Treat X-Linked Hypophosphataemia (XLH)
- Kyowa Kirin: New Data Analysis Shows Link between Blood Involvement and Response to Treatment in Cutaneous T-cell Lymphoma (CTCL) Patients
- Kyowa Kirin Receives Positive CHMP Opinion for the Self-administration of CRYSVITA® ▼ (burosumab) to Treat X-Linked Hypophosphataemia (XLH), a Rare Metabolic Bone Disorder
Kyowa Kirin Co Ltd (4151:DEU) closed at 28.00, -9.09% below its 52-week high of 30.80, set on Jul 08, 2021.
20.20Dec 18 202030.80Jul 08 2021
Markit short selling activity
|Market cap||2.01tn JPY|
|EPS (TTM)||85.78 |
|Annual div (ADY)||0.3467 |
|Annual div yield (ADY)||1.24%|
|Div ex-date||Jun 29 2021|
|Next div ex-date||Dec 29 2021|
|Next div pay-date||--|
Data delayed at least 15 minutes, as of Jul 23 2021 18:31 BST.